CERTIFIED H-1B FY 2025

Principal Pharmacovigilance Scientist

Takeda Development Center Americas, Inc. · Cambridge, Massachusetts

Case #I-200-25239-271588

In FY2025, Takeda Development Center Americas, Inc. sought H-1B sponsorship for a Principal Pharmacovigilance Scientist in Cambridge, Massachusetts at $159k per year, which is 11% above the prevailing wage of $144k. The case was certified in 8 days during the FY FY2025 cycle. This position is for continued employment.

$159k
Annual Salary
$144k
Prevailing Wage
+10.5%
Wage Premium
1
Positions

Filing Details

Case NumberI-200-25239-271588
Case StatusCertified
Visa ClassH-1B
Fiscal YearFY 2025
EmployerTakeda Development Center Americas, Inc.
Employer LocationCambridge, Massachusetts
Job TitlePrincipal Pharmacovigilance Scientist
SOC Code19-102100 – Biochemists and Biophysicists
WorksiteCambridge, Massachusetts
Annual Wage$159k
Prevailing Wage$144k
Wage Premium+10.5%
Positions1 (0 new, 1 continued)

Timeline

Aug 27, 2025
Received
Sep 4, 2025
Decision
Jan 16, 2026
Employment Start
Jan 15, 2029
Employment End

More Filings from Takeda Development Center Americas, Inc.

Job TitleSalaryStatusDate
Head HRBL, Global Research $306k CERTIFIED Jul 1, 2025
Research and Development (R&D) Investor Relations Lead, Seni $293k CERTIFIED Feb 3, 2025
IT Solution Product Engineer $173k CERTIFIED Sep 17, 2025
Product Manager $215k CERTIFIED Sep 9, 2025
GRA Device Team Lead, PDT $186k CERTIFIED Sep 9, 2025

View all Takeda Development Center Americas, Inc. filings →

Explore More

About This H-1B Filing

This Labor Condition Application (LCA) was filed by Takeda Development Center Americas, Inc. for the position of Principal Pharmacovigilance Scientist in Cambridge, Massachusetts. The offered annual salary is $159k, compared to the prevailing wage of $144k for this occupation and location. This represents a wage premium of +10.5% above the prevailing wage.

The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.

Case status: Certified. This means the Department of Labor has certified that the employer meets the wage and working condition requirements.

Understanding This LCA Filing

A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.

Why Employers File LCAs

When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, Takeda Development Center Americas, Inc. filed LCA case number I-200-25239-271588 to sponsor a Principal Pharmacovigilance Scientist position at their worksite in Cambridge, Massachusetts. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.

What Wage Levels Mean

The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:

For this filing, the offered wage of $159k compares to the DOL prevailing wage of $144k for Biochemists and Biophysicists positions in the Cambridge, Massachusetts area. The positive wage premium of +10.5% indicates the employer is offering above the DOL-determined average for this occupation and location.

What is Prevailing Wage?

The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.

How to Interpret This Data

What Certified Means for This Application

A "Certified" status means the DOL has reviewed Takeda Development Center Americas, Inc.'s attestations and determined that the LCA meets all regulatory requirements. The employer has demonstrated that the offered wage of $159k meets or exceeds the prevailing wage for Principal Pharmacovigilance Scientist positions in the Cambridge, Massachusetts area. It is important to understand that LCA certification does not guarantee H-1B visa approval. The next step is for the employer to file Form I-129 with USCIS, which evaluates whether the position qualifies as a specialty occupation and whether the beneficiary has the required qualifications.

Processing Time

This LCA was received by the DOL on Aug 27, 2025 and a decision was rendered on Sep 4, 2025, a processing time of approximately 8 business days. The standard DOL processing time for LCA applications is 7 to 10 business days. This application was processed within the standard timeframe.

Comparing to Industry Standards

The offered salary of $159k for this Principal Pharmacovigilance Scientist position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 19-102100 (Biochemists and Biophysicists), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.

Frequently Asked Questions

What is the salary for this Principal Pharmacovigilance Scientist position?

The offered annual salary for this Principal Pharmacovigilance Scientist position at Takeda Development Center Americas, Inc. is $159k. The Department of Labor prevailing wage for this occupation and location is $144k. The offered wage represents a +10.5% premium over the prevailing wage.

Where is this Principal Pharmacovigilance Scientist job located?

This H-1B filing is for a position located in Cambridge, Massachusetts. The employing company, Takeda Development Center Americas, Inc., is headquartered in Cambridge, Massachusetts.

What visa type is this filing for?

This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.

Who is the employer for this H-1B filing?

The employer for this filing is Takeda Development Center Americas, Inc., located in Cambridge, Massachusetts. Takeda Development Center Americas, Inc. filed this Labor Condition Application (case number I-200-25239-271588) for a Principal Pharmacovigilance Scientist position during fiscal year FY 2025. View all Takeda Development Center Americas, Inc. H-1B filings.

What does LCA “Certified” mean?

Certified means the U.S. Department of Labor has approved this Labor Condition Application, confirming that Takeda Development Center Americas, Inc. has attested to meeting all wage and working condition requirements. A certified LCA does not guarantee H-1B visa approval — the employer must still file a separate petition (Form I-129) with USCIS.

Related Guides